Showing results (1-10 of 466) with videos related to
Sort By:
Pageof 47
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
Pharmacogenetics of dextromethorphan O-demethylation in manA Küpfer, B Schmid, G PfaffClinical Pharmacology and Therapeutics|December 1, 1985
Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylationB Schmid, J Bircher, R Preisig, et al.European Journal of Clinical Pharmacology|January 1, 1984
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in manA Küpfer, R PreisigBritish Journal of Clinical Pharmacology|April 1, 1984
Urinary bile acid and bile alcohol excretion does not reflect the genetic polymorphism of debrisoquine hydroxylationG Karlaganis, A Küpfer, R PreisigThe Journal of Pharmacology and Experimental Therapeutics|December 1, 1977
Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dogA Küpfer, J Bircher, R PreisigClinical Pharmacology and Therapeutics|October 1, 1976
Aminopyrine demethylation measured by breath analysis in cirrhosisJ Bircher, A Küpfer, I Gikalov, et al.European Journal of Clinical Investigation|August 1, 1978
Polymorphic acetylation and aminopyrine demethylation in Gilbert's syndromeR Platzer, A Küpfer, J Bircher, et al.European Journal of Clinical Pharmacology|January 1, 1986
Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarateH Saner, H P Gurtner, R Preisig, et al.Schweizerische Medizinische Wochenschrift|July 24, 1982
[Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]B Dick, A Küpfer, J Molnàr, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1984
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humansA Küpfer, R Patwardhan, S Ward, et al.Pageof 47